☆ 4.7 Editorial Material

The emerging era of staging Alzheimer's disease pathology using plasma biomarkers

BRAIN (2023)

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease

Antoine Leuzy et al.

Summary: This study investigated longitudinal tau PET findings across the clinical continuum of Alzheimer's disease and identified biomarker combinations with strong associations for predicting longitudinal tau PET, aiming to optimize clinical trial enrichment strategies.

JAMA NEUROLOGY (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Rik Ossenkoppele et al.

Summary: Abnormal amyloid and tau PET in cognitively unimpaired individuals is strongly associated with short-term cognitive decline and subsequent development of dementia.

NATURE MEDICINE (2022)

Add to Collection
Article Medicine, General & Internal

Donanemab in Early Alzheimer's Disease

Mark A. Mintun et al.

Summary: In this study, donanemab showed improved composite scores for cognition and daily living activities compared to placebo in patients with early Alzheimer's disease at 76 weeks, although secondary outcomes varied. Longer and larger trials are needed to further explore the efficacy and safety of donanemab in Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Biomarkers for neurodegenerative diseases

Oskar Hansson

Summary: Biomarkers for neurodegenerative diseases play a crucial role in improving diagnostic workup and therapy monitoring, with emerging blood-based markers and discussions on their implementation in clinical practice and trials.

NATURE MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection
Article Clinical Neurology

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

Niklas Mattsson et al.

JAMA NEUROLOGY (2019)

Add to Collection
Article Clinical Neurology

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

DR Thal et al.

NEUROLOGY (2002)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.